These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36346309)

  • 1. Intravenous immunoglobulin for chronic residual peripheral neuropathy in microscopic polyangiitis: A multicentre randomised double-blind trial.
    Arimura Y; Sobue G; Hattori N; Takashima H; Harigai M; Nagata K; Makino H
    Mod Rheumatol; 2023 Nov; 33(6):1125-1136. PubMed ID: 36346309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a multicenter, double-blind trial.
    Koike H; Akiyama K; Saito T; Sobue G;
    J Neurol; 2015 Mar; 262(3):752-9. PubMed ID: 25577176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC).
    Bus SRM; Zambreanu L; Abbas A; Rajabally YA; Hadden RDM; de Haan RJ; de Borgie CAJM; Lunn MP; van Schaik IN; Eftimov F;
    Trials; 2021 Feb; 22(1):155. PubMed ID: 33608058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
    Hughes R; Dalakas MC; Merkies I; Latov N; Léger JM; Nobile-Orazio E; Sobue G; Genge A; Cornblath D; Merschhemke M; Ervin CM; Agoropoulou C; Hartung HP;
    Lancet Neurol; 2018 Aug; 17(8):689-698. PubMed ID: 30001923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.
    Léger JM; Chassande B; Musset L; Meininger V; Bouche P; Baumann N
    Brain; 2001 Jan; 124(Pt 1):145-53. PubMed ID: 11133794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy.
    Comi G; Roveri L; Swan A; Willison H; Bojar M; Illa I; Karageorgiou C; Nobile-Orazio E; van den Bergh P; Swan T; Hughes R; Aubry J; Baumann N; Hadden R; Lunn M; Knapp M; Léger JM; Bouche P; Mazanec R; Meucci N; van der Meché F; Toyka K;
    J Neurol; 2002 Oct; 249(10):1370-7. PubMed ID: 12382151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study").
    Aggarwal R; Charles-Schoeman C; Schessl J; Dimachkie MM; Beckmann I; Levine T
    Medicine (Baltimore); 2021 Jan; 100(1):e23677. PubMed ID: 33429735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.
    Hahn AF; Bolton CF; Zochodne D; Feasby TE
    Brain; 1996 Aug; 119 ( Pt 4)():1067-77. PubMed ID: 8813271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled trial: intravenous immunoglobulin treatment in patients with diffuse cutaneous systemic sclerosis.
    Takehara K; Ihn H; Sato S
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):151-6. PubMed ID: 23910617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.
    Aggarwal R; Schessl J; Charles-Schoeman C; Bata-Csörgő Z; Dimachkie MM; Griger Z; Moiseev S; Oddis CV; Schiopu E; Vencovský J; Beckmann I; Clodi E; Levine T;
    Arthritis Res Ther; 2024 Jan; 26(1):27. PubMed ID: 38233885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
    Eftimov F; Winer JB; Vermeulen M; de Haan R; van Schaik IN
    Cochrane Database Syst Rev; 2009 Jan; (1):CD001797. PubMed ID: 19160200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study.
    Vermeulen M; van Doorn PA; Brand A; Strengers PF; Jennekens FG; Busch HF
    J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):36-9. PubMed ID: 8429321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of high-dose intravenous immunoglobulin therapy for peripheral neuropathy in the remission stage of eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome).
    Matsuda T; Arimura Y; Yoshihara K; Komagata Y; Kaname S; Yamada A
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(4):217-25. PubMed ID: 23994800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies.
    Gibbons CH; Rajan S; Senechal K; Hendry E; McCallister B; Levine TD
    Muscle Nerve; 2023 May; 67(5):363-370. PubMed ID: 36367813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study.
    Van den Berg LH; Kerkhoff H; Oey PL; Franssen H; Mollee I; Vermeulen M; Jennekens FG; Wokke JH
    J Neurol Neurosurg Psychiatry; 1995 Sep; 59(3):248-52. PubMed ID: 7673950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group.
    Fazekas F; Deisenhammer F; Strasser-Fuchs S; Nahler G; Mamoli B
    Lancet; 1997 Mar; 349(9052):589-93. PubMed ID: 9057729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris.
    Arnold DF; Burton J; Shine B; Wojnarowska F; Misbah SA
    Br J Dermatol; 2009 May; 160(5):1098-102. PubMed ID: 19222460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial.
    de Greef BT; Geerts M; Hoeijmakers JG; Faber CG; Merkies IS
    Trials; 2016 Jul; 17(1):330. PubMed ID: 27439408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial.
    Hill M; Iro M; Sadarangani M; Absoud M; Cantrell L; Chong K; Clark C; Easton A; Gray V; Kneen R; Lim M; Liu X; Pike M; Solomon T; Vincent A; Willis L; Yu LM; Pollard AJ;
    BMJ Open; 2023 Nov; 13(11):e072134. PubMed ID: 37945292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.